Updates to the McDonald diagnostic criteria for MS
Description
The 2024 revision of the McDonald diagnostic criteria for multiple sclerosis (MS) was recently presented at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2024). Key updates include the recognition of optic nerve lesions, the incorporation of cerebrospinal fluid (CSF) kappa-free light chains as a diagnostic biomarker, and the addition of central vein sign (CVS) and paramagnetic rim lesions (PRLs) as imaging markers.
This podcast features experts Marcello Moccia, MD, PhD, University of Naples Federico II, Naples, Italy, Serena Borrelli, MD, Université catholique de Louvain & Hôpital Erasme, Université Libre de Brussels, Brussels, Belgium, Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, and Giancarlo Comi, MD, Vita-Salute San Raffaele University, Milan, Italy, who discuss the updates. They delve into the diagnostic value of CVS, PRLs, and optic nerve lesions, and speak about the implementation of these new guidelines into clinical practice.
The post Updates to the McDonald diagnostic criteria for MS appeared first on VJNeurology.
United States
